On Nov 18, 2021 Generate Biomedicines closed a Series B round and raised $370,000,000 from Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, ARCH Venture Partners, Fidelity Management and Research Company, Flagship Pioneering, Morningside Ventures, T. Rowe Price, featuring lead investors .

About the company: Generate Biomedicines is located at United States, North America.
“Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering.”

Company website: http://www.generatebiomedicines.com

Leave a Reply

Your email address will not be published. Required fields are marked *